Trial · NCT03355664
Adverse events56
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 56
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | vomiting | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 3 | 154 | |
| other | vomiting | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 12 | 156 | |
| other | nausea | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 3 | 154 | |
| other | nausea | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 11 | 156 | |
| other | dizziness | General disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 9 | 154 | |
| other | dizziness | General disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 16 | 156 | |
| other | abdominal pain | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 19 | 154 | |
| other | abdominal pain | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 22 | 156 | |
| other | diarrhoea | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 13 | 154 | |
| other | diarrhoea | Gastrointestinal disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 17 | 156 | |
| other | headache | General disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 19 | 154 | |
| other | headache | General disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 20 | 156 | |
| other | fatigue | General disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 11 | 154 | |
| other | fatigue | General disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 15 | 156 | |
| other | loss of appetite | General disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 9 | 154 | |
| other | loss of appetite | General disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 9 | 156 | |
| other | itching | Skin and subcutaneous tissue disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 2 | 154 | |
| other | itching | Skin and subcutaneous tissue disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 5 | 156 | |
| other | blurred vision | Eye disorders | Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24 | 7 | 154 | |
| other | blurred vision | Eye disorders | Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24 | 4 | 156 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03355664/events